Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis

This publication has 47 references indexed in Scilit:

• EFFECT OF SILYMARIN ON LIPID AND ALCOHOL METABOLISM IN MICE FOLLOWING LONG-TERM ALCOHOL CONSUMPTION
  Journal of Food Biochemistry, 2011
• From the metabolic syndrome to NAFLD or vice versa?
  Digestive and Liver Disease, 2010
• Pathology of nonalcoholic fatty liver disease
  Nature Reviews Gastroenterology & Hepatology, 2010
• Harmonizing the Metabolic Syndrome
  Circulation, 2009
• In vitroantioxidant activity of silymarin
  Journal of Enzyme Inhibition and Medicinal Chemistry, 2009
• Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome
  Fertility and Sterility, 2008
• An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
  Research in Complementary Medicine, 2008
• Silymarin as an Adjunct to Glibenclamide Therapy Improves Long-Term and Postprandial Glycemic Control and Body Mass Index in Type 2 Diabetes
  Journal of Medicinal Food, 2007
• Long-term (23 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients
  Journal of Hepatology, 1997
• Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin
  Hepatology, 1996